NS 220

Drug Profile

NS 220

Alternative Names: NS-220; R 1593

Latest Information Update: 24 May 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nippon Shinyaku
  • Class Antihyperlipidaemics; Dioxanes; Oxazoles; Small molecules
  • Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Atherosclerosis; Lipid metabolism disorders; Type 2 diabetes mellitus

Most Recent Events

  • 24 May 2010 Discontinued - Preclinical for Atherosclerosis in Japan (unspecified route)
  • 24 May 2010 Discontinued - Preclinical for Lipid metabolism disorders in Japan (unspecified route)
  • 24 May 2010 Discontinued - Preclinical for Type-2 diabetes mellitus in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top